Partnership

PEP-Therapy values collaborations and partnerships with pharma and biotech partners, clinical organizations, academic institutions and investors to accelerate the development of PEP-010 and further CP&IP-based products.

​

PEP-Therapy’s Cell Penetrating & Interfering Peptide technology (CP&IP) can also be applied to other peptides for in-licensing and co-development partnerships.

​

For partnering opportunities, please contact us.